Scientists may have uncovered a new mechanism for treating Alzheimer's disease, offering hope to millions of patients worldwide. The discovery involves the activation of the brain's cellular clean ...

No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S. Food and Drug Administration (FDA) approved Cobenfy for the psychiatric ...

The Dodgers right-hander is back on the injured list with right shoulder inflammation. This ends his regular season, but the team is still hopeful Graterol might return at some point during the ...

Kristen Fischer, an American who visited India with her husband in 2017 for the first time, has been residing in Delhi for the past two years. Fischer is now a content creator with over 60,000 ...

Here’s our process. The best mattresses for shoulder pain may vary based on where your pain occurs, price, type, material, firmness level, and how you sleep. Certain mattresses may be better for ...

Researchers believe that studying these individuals, who represent about one in 200 of those infected with HIV, could lead to new treatments or even a cure. “One of the key questions is whether there ...

The off-shoulder ensemble reached her ankle and had a cutout at the back. Manu styled the outfit with a diamond necklace and matching earrings. She wore a white flower bracelet in one hand and a ...

Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive tumors. Researchers at the Francis Crick Institute ...

They pledged to work together on a range of initiatives, from Coast Guard patrols to cancer-treatment efforts to scientific-research fellowships. India’s enthusiasm for the Quad—revived by ...

There is a simple discount patient access scheme for trifluridine–tipiracil. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...

About one in 300 people worldwide are affected by schizophrenia, but for decades treatment options have been both static and limited. If the FDA approves the twice-daily pill on Thursday ...